DexCom EBITDA Margin 2010-2024 | DXCM

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for DexCom (DXCM) over the last 10 years. The current EBITDA margin for DexCom as of March 31, 2024 is .
DexCom EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-03-31 $3.80B $0.85B 22.33%
2023-12-31 $3.62B $0.78B 21.64%
2023-09-30 $3.40B $0.68B 19.89%
2023-06-30 $3.20B $0.61B 19.07%
2023-03-31 $3.02B $0.56B 18.49%
2022-12-31 $2.91B $0.55B 18.83%
2022-09-30 $2.79B $0.42B 15.00%
2022-06-30 $2.67B $0.38B 14.07%
2022-03-31 $2.57B $0.38B 14.77%
2021-12-31 $2.45B $0.37B 15.07%
2021-09-30 $2.32B $0.46B 19.84%
2021-06-30 $2.17B $0.43B 19.77%
2021-03-31 $2.03B $0.39B 19.09%
2020-12-31 $1.93B $0.37B 19.05%
2020-09-30 $1.82B $0.36B 19.71%
2020-06-30 $1.72B $0.32B 18.36%
2020-03-31 $1.60B $0.24B 15.19%
2019-12-31 $1.48B $0.19B 12.94%
2019-09-30 $1.35B $-0.08B -6.00%
2019-06-30 $1.22B $-0.13B -10.47%
2019-03-31 $1.13B $-0.14B -12.13%
2018-12-31 $1.03B $-0.16B -15.21%
2018-09-30 $0.92B $0.02B 1.64%
2018-06-30 $0.83B $-0.00B -0.36%
2018-03-31 $0.76B $-0.02B -1.97%
2017-12-31 $0.72B $-0.03B -3.76%
2017-09-30 $0.67B $-0.05B -6.88%
2017-06-30 $0.63B $-0.06B -10.11%
2017-03-31 $0.60B $-0.07B -11.69%
2016-12-31 $0.57B $-0.05B -8.55%
2016-09-30 $0.53B $-0.04B -7.88%
2016-06-30 $0.49B $-0.07B -13.91%
2016-03-31 $0.45B $-0.05B -11.91%
2015-12-31 $0.40B $-0.05B -11.69%
2015-09-30 $0.36B $-0.05B -13.24%
2015-06-30 $0.32B $-0.01B -3.13%
2015-03-31 $0.29B $-0.01B -4.56%
2014-12-31 $0.26B $-0.01B -5.02%
2014-09-30 $0.23B $-0.02B -7.49%
2014-06-30 $0.20B $-0.02B -8.96%
2014-03-31 $0.18B $-0.02B -12.36%
2013-12-31 $0.16B $-0.02B -13.04%
2013-09-30 $0.14B $-0.03B -19.01%
2013-06-30 $0.12B $-0.04B -31.15%
2013-03-31 $0.11B $-0.04B -39.45%
2012-12-31 $0.10B $-0.05B -48.48%
2012-09-30 $0.09B $-0.05B -60.23%
2012-06-30 $0.08B $-0.05B -60.24%
2012-03-31 $0.08B $-0.04B -53.09%
2011-12-31 $0.08B $-0.04B -53.33%
2011-09-30 $0.07B $-0.04B -55.07%
2011-06-30 $0.06B $-0.04B -60.32%
2011-03-31 $0.05B $-0.04B -77.78%
2010-12-31 $0.05B $-0.04B -82.00%
2010-09-30 $0.04B $-0.04B -93.18%
2010-06-30 $0.04B $-0.04B -102.56%
2010-03-31 $0.03B $-0.04B -123.53%
2009-12-31 $0.03B $-0.04B -144.83%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $52.240B $3.622B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $227.236B 27.53
Intuitive Surgical (ISRG) United States $141.461B 85.22
Edwards Lifesciences (EW) United States $53.716B 34.96
IDEXX Laboratories (IDXX) United States $44.882B 52.61
Alcon (ALC) Switzerland $43.802B 31.39
IQVIA Holdings (IQV) United States $42.121B 24.44
STERIS (STE) Ireland $22.993B 26.87
Waters (WAT) United States $21.115B 31.03
SONOVA HOLDING (SONVY) Switzerland $19.146B 0.00
Hologic (HOLX) United States $17.508B 19.59
Fresenius Medical Care AG KGaA (FMS) Germany $12.893B 15.05
ShockWave Medical (SWAV) United States $12.394B 77.13
Sysmex ADR (SSMXY) Japan $11.077B 34.74
Teleflex (TFX) United States $10.251B 15.96
Globus Medical (GMED) United States $8.718B 25.56
Penumbra (PEN) United States $7.890B 89.66
Masimo (MASI) United States $6.588B 37.95
Glaukos (GKOS) United States $5.530B 0.00
TransMedics (TMDX) United States $4.545B 431.19
Integer Holdings (ITGR) United States $4.051B 24.48
PROCEPT BioRobotics (PRCT) United States $3.502B 0.00
LivaNova (LIVN) United Kingdom $3.355B 19.92
Tandem Diabetes Care (TNDM) United States $3.055B 0.00
Elekta AB (EKTAY) Sweden $2.926B 20.07
Inari Medical (NARI) United States $2.660B 0.00
Nihon Kohden (NHNKY) Japan $2.485B 21.02
RxSight (RXST) United States $2.243B 0.00
Integra LifeSciences Holdings (IART) United States $2.170B 9.46
Veracyte (VCYT) United States $1.749B 0.00
Alphatec Holdings (ATEC) United States $1.546B 0.00
Artivion (AORT) United States $0.978B 93.84
AVANOS MEDICAL, INC (AVNS) United States $0.936B 18.20
OPKO Health (OPK) United States $0.920B 0.00
Silk Road Medical (SILK) United States $0.875B 0.00
OrthoPediatrics (KIDS) United States $0.763B 0.00
Mesa Laboratories (MLAB) United States $0.659B 22.39
Paragon 28 (FNA) United States $0.635B 0.00
SiBone (SIBN) United States $0.615B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.563B 0.00
Pacific Biosciences Of California (PACB) United States $0.550B 0.00
IRadimed (IRMD) United States $0.532B 29.81
Pulse Biosciences (PLSE) United States $0.431B 0.00
Nevro (NVRO) United States $0.419B 0.00
Tactile Systems Technology (TCMD) United States $0.326B 11.16
Treace Medical Concepts (TMCI) United States $0.310B 0.00
Sight Sciences (SGHT) United States $0.266B 0.00
AxoGen (AXGN) United States $0.264B 0.00
EDAP TMS S.A (EDAP) France $0.249B 0.00
AngioDynamics (ANGO) United States $0.242B 0.00
908 Devices (MASS) United States $0.236B 0.00
NeuroPace (NPCE) United States $0.235B 0.00
Delcath Systems (DCTH) United States $0.210B 0.00
Inogen (INGN) United States $0.208B 0.00
Atossa Genetics (ATOS) United States $0.197B 0.00
Alpha Tau Medical (DRTS) Israel $0.197B 0.00
CVRx (CVRX) United States $0.179B 0.00
ClearPoint Neuro (CLPT) United States $0.170B 0.00
Semler Scientific (SMLR) United States $0.163B 8.25
Accuray (ARAY) United States $0.162B 0.00
Spectral Diagnostics (EDTXF) Canada $0.108B 0.00
KORU Medical Systems (KRMD) United States $0.104B 0.00
Sensus Healthcare (SRTS) United States $0.097B 20.45
Yubo Biotech (YBGJ) China $0.095B 0.00
Neuronetics (STIM) United States $0.078B 0.00
EnVVeno Medical (NVNO) United States $0.067B 0.00
Monogram Orthopaedics (MGRM) United States $0.066B 0.00
Hyperfine (HYPR) United States $0.064B 0.00
Vicarious Surgical (RBOT) United States $0.062B 0.00
Envoy Medical (COCH) United States $0.061B 0.00
InspireMD (NSPR) Israel $0.057B 0.00
DarioHealth (DRIO) United States $0.057B 0.00
SEP Acquisition (SEPA) United States $0.049B 0.00
Lucid Diagnostics (LUCD) United States $0.047B 0.00
Autonomix Medical (AMIX) United States $0.047B 0.00
LENSAR (LNSR) United States $0.047B 0.00
ReWalk Robotics (LFWD) Israel $0.044B 0.00
Precision Optics (POCI) United States $0.039B 0.00
Pixie Dust Technologies (PXDT) Japan $0.036B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
Aspira Women's Health (AWH) United States $0.033B 0.00
T2 Biosystems (TTOO) United States $0.031B 0.00
Spectral AI (MDAI) United States $0.031B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.029B 0.00
Ekso Bionics Holdings (EKSO) United States $0.025B 0.00
Accelerate Diagnostics (AXDX) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
Biosig Technologies (BSGM) United States $0.018B 0.00
PAVmed (PAVM) United States $0.017B 0.00
NexGel (NXGL) United States $0.015B 0.00
Microbot Medical (MBOT) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.010B 0.00
Avinger (AVGR) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00